Related Experiment Video
Updated: Mar 14, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
988
MR-based prognostic nomogram for prostate cancer after radical prostatectomy
Yu-Dong Zhang1, Chen-Jiang Wu1, Mei-Ling Bao2
1Department of Radiology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Journal of Magnetic Resonance Imaging : JMRI
|September 23, 2016
Summary
A new MRI-based nomogram accurately predicts prostate cancer recurrence within 3 years after surgery. This imaging tool improves upon existing clinical scoring systems for better patient outcomes.
Area of Science:
- Radiology and Oncology
- Medical Imaging Analysis
- Prostate Cancer Research
Background:
- Prostate cancer (PCa) biochemical recurrence (BCR) after prostatectomy poses a significant clinical challenge.
- Accurate prediction of BCR is crucial for guiding post-operative management and patient counseling.
Purpose of the Study:
- To develop and validate a magnetic resonance imaging (MRI)-based nomogram for predicting PCa BCR within three years post-prostatectomy.
- To assess the added value of MRI features to established clinical risk stratification schemes (D'Amico and CAPRA).
Main Methods:
- Retrospective analysis of pre-operative MRI features in 205 PCa patients.
- Utilized partial least square regression and multivariable Cox regression to identify predictors of BCR.
- Integrated imaging features into D'Amico and CAPRA scores to evaluate performance enhancement.
Main Results:
- The MRI nomogram demonstrated a high predictive accuracy (Az = 0.909) for 3-year BCR.
- Incorporating MRI findings significantly improved the performance of D'Amico (Az = 0.901) and CAPRA (Az = 0.894) scores.
- Independent predictors of BCR included tumor apparent diffusion coefficients (ADCs), PI-RADS score, Gleason score, and pathological T-stage (T3b).
Conclusions:
- Multiparametric MRI, when integrated into a prognostic nomogram, offers a powerful tool for predicting clinical outcomes in prostate cancer patients.
- This MRI-based approach enhances the accuracy of risk stratification beyond traditional clinical factors.
